Segal Lloyd Mitchell has filed 15 insider transactions across 2 companies since January 2023.
Most recent transaction: a transaction of 19631 shares of Aktis Oncology, Inc. ($AKTS) on January 12, 2026.
Activity breakdown: 0 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | Aktis Oncology, Inc. | $AKTS | Segal Lloyd Mitchell | Not found | C | Common Stock | 19631 | $0.00 | 19,631.0000 | 0 | 9999.99% | 0.00% |
| Jan. 12, 2026 | Aktis Oncology, Inc. | $AKTS | Segal Lloyd Mitchell | Not found | C | Series B Redeemable Convertible Preferred Stock | 24687 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 12, 2026 | Aktis Oncology, Inc. | $AKTS | Segal Lloyd Mitchell | Not found | C | Series A Redeemable Convertible Preferred Stock | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 12, 2025 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 21179 | $1.14 | 231,952.0000 | 42,411,085 | 8.37% | 0.05% |
| March 4, 2025 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | PRESIDENT AND CEO | A | Employee Stock Option (right to buy) | 237000 | $0.00 | 237,000.0000 | 42,411,085 | 9999.99% | 0.56% |
| March 4, 2025 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | PRESIDENT AND CEO | A | Common Shares | 40000 | $0.00 | 253,131.0000 | 42,411,085 | 18.77% | 0.09% |
| April 1, 2024 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 2491 | $4.63 | 210,236.0000 | 42,093,293 | 1.17% | 0.01% |
| March 28, 2024 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 2650 | $4.62 | 212,727.0000 | 42,093,293 | 1.23% | 0.01% |
| March 26, 2024 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 2650 | $4.64 | 211,193.0000 | 42,093,293 | 1.24% | 0.01% |
| March 27, 2024 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 2650 | $4.63 | 208,543.0000 | 42,093,293 | 1.25% | 0.01% |
| March 25, 2024 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | PRESIDENT AND CEO | S | Common Shares | 2650 | $4.79 | 213,843.0000 | 42,093,293 | 1.22% | 0.01% |
| March 1, 2024 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | PRESIDENT AND CEO | A | Employee Stock Option (right to buy) | 237000 | $0.00 | 237,000.0000 | 42,093,293 | 9999.99% | 0.56% |
| March 1, 2024 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | PRESIDENT AND CEO | A | Common Shares | 40000 | $0.00 | 219,143.0000 | 42,093,293 | 22.33% | 0.10% |
| Jan. 30, 2023 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | President and CEO | A | Employee Stock Option (right to buy) | 344200 | $0.00 | 344,200.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2023 | Repare Therapeutics Inc. | $RPTX | Segal Lloyd Mitchell | President and CEO | A | Common Shares | 78550 | $0.00 | 179,143.0000 | 0 | 78.09% | 0.00% |